Abstract:A differentiated beta-cell results not only from cell-specific gene expression, but also from cell-selective repression of certain housekeeping genes. Indeed, to prevent insulin toxicity, beta-cells should handle insulin stores carefully, preventing exocytosis under conditions when circulating insulin is unwanted. Some ubiquitously expressed proteins would significantly jeopardize this safeguard, when allowed to function in beta-cells. This is illustrated by two studied examples. First, low-K(m) hexokinases ar… Show more
“…Our results therefore confirm previous studies in which protein expression and activity of GPD2 have been shown to be similar in primary sorted β-cells and the INS-1 cell line, being about 10-fold higher in these cells compared with islet non-β-cells [54]. Furthermore, expression of Gpd2 has previously been studied in conjunction with the β-cell 'disallowed' gene Ldh [58]; the ratio of Gpd2-to-Ldh was found to be two to three orders of magnitude greater in primary β-cells and INS-1 cells than in other islet cells [54]. Moreover, impairments in the glycerol phosphate shuttle have been observed in animal models of T2D [59,60] and in T-lymphocytes from T2D patients [61].…”
Section: Figure 8 Gsis From Mouse Islets Is Unaffected By Phs Whereasupporting
Altered secretion of insulin as well as glucagon has been implicated in the pathogenesis of Type 2 diabetes (T2D), but the mechanisms controlling glucagon secretion from α-cells largely remain unresolved. Therefore, we studied the regulation of glucagon secretion from αTC1-6 (αTC1 clone 6) cells and compared it with insulin release from INS-1 832/13 cells. We found that INS-1 832/13 and αTC1-6 cells respectively secreted insulin and glucagon concentration-dependently in response to glucose. In contrast, tight coupling of glycolytic and mitochondrial metabolism was observed only in INS-1 832/13 cells. Although glycolytic metabolism was similar in the two cell lines, TCA (tricarboxylic acid) cycle metabolism, respiration and ATP levels were less glucose-responsive in αTC1-6 cells. Inhibition of the malate-aspartate shuttle, using phenyl succinate (PhS), abolished glucose-provoked ATP production and hormone secretion from αTC1-6 but not INS-1 832/13 cells. Blocking the malate-aspartate shuttle increased levels of glycerol 3-phosphate only in INS-1 832/13 cells. Accordingly, relative expression of constituents in the glycerol phosphate shuttle compared with malate-aspartate shuttle was lower in αTC1-6 cells. Our data suggest that the glycerol phosphate shuttle augments the malate-aspartate shuttle in INS-1 832/13 but not αTC1-6 cells. These results were confirmed in mouse islets, where PhS abrogated secretion of glucagon but not insulin. Furthermore, expression of the rate-limiting enzyme of the glycerol phosphate shuttle was higher in sorted primary β-than in α-cells. Thus, suppressed glycerol phosphate shuttle activity in the α-cell may prevent a high rate of glycolysis and consequently glucagon secretion in response to glucose. Accordingly, pyruvate-and lactate-elicited glucagon secretion remains unaffected since their signalling is independent of mitochondrial shuttles.
“…Our results therefore confirm previous studies in which protein expression and activity of GPD2 have been shown to be similar in primary sorted β-cells and the INS-1 cell line, being about 10-fold higher in these cells compared with islet non-β-cells [54]. Furthermore, expression of Gpd2 has previously been studied in conjunction with the β-cell 'disallowed' gene Ldh [58]; the ratio of Gpd2-to-Ldh was found to be two to three orders of magnitude greater in primary β-cells and INS-1 cells than in other islet cells [54]. Moreover, impairments in the glycerol phosphate shuttle have been observed in animal models of T2D [59,60] and in T-lymphocytes from T2D patients [61].…”
Section: Figure 8 Gsis From Mouse Islets Is Unaffected By Phs Whereasupporting
Altered secretion of insulin as well as glucagon has been implicated in the pathogenesis of Type 2 diabetes (T2D), but the mechanisms controlling glucagon secretion from α-cells largely remain unresolved. Therefore, we studied the regulation of glucagon secretion from αTC1-6 (αTC1 clone 6) cells and compared it with insulin release from INS-1 832/13 cells. We found that INS-1 832/13 and αTC1-6 cells respectively secreted insulin and glucagon concentration-dependently in response to glucose. In contrast, tight coupling of glycolytic and mitochondrial metabolism was observed only in INS-1 832/13 cells. Although glycolytic metabolism was similar in the two cell lines, TCA (tricarboxylic acid) cycle metabolism, respiration and ATP levels were less glucose-responsive in αTC1-6 cells. Inhibition of the malate-aspartate shuttle, using phenyl succinate (PhS), abolished glucose-provoked ATP production and hormone secretion from αTC1-6 but not INS-1 832/13 cells. Blocking the malate-aspartate shuttle increased levels of glycerol 3-phosphate only in INS-1 832/13 cells. Accordingly, relative expression of constituents in the glycerol phosphate shuttle compared with malate-aspartate shuttle was lower in αTC1-6 cells. Our data suggest that the glycerol phosphate shuttle augments the malate-aspartate shuttle in INS-1 832/13 but not αTC1-6 cells. These results were confirmed in mouse islets, where PhS abrogated secretion of glucagon but not insulin. Furthermore, expression of the rate-limiting enzyme of the glycerol phosphate shuttle was higher in sorted primary β-than in α-cells. Thus, suppressed glycerol phosphate shuttle activity in the α-cell may prevent a high rate of glycolysis and consequently glucagon secretion in response to glucose. Accordingly, pyruvate-and lactate-elicited glucagon secretion remains unaffected since their signalling is independent of mitochondrial shuttles.
“…When examining these figures, it should be born in mind that the overall islet mRNA profile reflects the mean of phenomena in different cell types. Thus, although most changes are likely to have occurred in beta cells (∼70-80% of islet mass), some may have occurred in non-beta cells, especially for genes normally disallowed in beta cells like the lactate/pyruvate transporter Mct1 (also known as Slc16a1) [1,38]. Please also note that changes in mRNA levels may result from altered transcription or mRNA stability and that the higher level of complexity due to alternative mRNA splicing was not addressed.…”
Section: Resultsmentioning
confidence: 99%
“…The ability of pancreatic beta cells to secrete insulin in response to nutrient stimulation depends on adequate expression of genes important for glycolysis, mitochondrial metabolism and insulin biosynthesis, such as preproinsulin, Glut2 (also known as Slc2a2) and glucokinase, and on the repression of genes potentially deleterious to beta cell function [1], including hexokinase 1 and lactate dehydrogenase A [2]. Besides acutely regulating insulin biosynthesis and secretion, subacute and prolonged changes in nutrient availability exert pleiotropic effects on the beta cell phenotype, such as altered function, survival, growth and differentiation [3][4][5][6].…”
Aims/hypothesis Survival and function of insulin-secreting pancreatic beta cells are markedly altered by changes in nutrient availability. In vitro, culture in 10 rather than 2 mmol/l glucose improves rodent beta cell survival and function, whereas glucose concentrations above 10 mmol/l are deleterious.
“…One of the deeply repressed genes in islets of Langerhans is Mct1, encoding the monocarboxylate transporter MCT1, which mediates the transport of lactate and pyruvate across cell membranes and is present in all tissues except adult beta-cells (Otonkoski et al 2007;Quintens et al 2008). Inadvertent expression of MCT1 in beta-cells results in hypoglycemia after physical exercise due to inappropriate insulin release (Otonkoski et al 2003).…”
Section: Disallowance In Islets Of Langerhansmentioning
confidence: 99%
“…Two studies previously reported on disallowance in islets (Quintens et al 2008;Pullen et al 2010), but this study is the first to analyze the phenomenon in a broad set of tissues and provide mechanistic insights. In summary, we propose that tissue-specific disallowance of housekeeping genes is required for the specialized function of differentiated tissues.…”
We report on a hitherto poorly characterized class of genes that are expressed in all tissues, except in one. Often, these genes have been classified as housekeeping genes, based on their nearly ubiquitous expression. However, the specific repression in one tissue defines a special class of “disallowed genes.” In this paper, we used the intersection-union test to screen for such genes in a multi-tissue panel of genome-wide mRNA expression data. We propose that disallowed genes need to be repressed in the specific target tissue to ensure correct tissue function. We provide mechanistic data of repression with two metabolic examples, exercise-induced inappropriate insulin release and interference with ketogenesis in liver. Developmentally, this repression is established during tissue maturation in the early postnatal period involving epigenetic changes in histone methylation. In addition, tissue-specific expression of microRNAs can further diminish these repressed mRNAs. Together, we provide a systematic analysis of tissue-specific repression of housekeeping genes, a phenomenon that has not been studied so far on a genome-wide basis and, when perturbed, can lead to human disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.